Coronavirus / Roche's New Test Gets FDA Emergency Use Authorization
Over the past few years, innovative Swiss giant Roche has combined its position as the world’s number 1 biotech…
USA
Coronavirus / How US Generics Firms are Responding to COVID-19 Supply Chain Risks
AAM Interim President Jeff Francer outlines the vital role that biosimilar and generics firms will play in filling supply chain gaps during the ongoing coronavirus pandemic. Like the rest…
AI / First Antibiotic Discovered Using Artificial Intelligence
Artificial intelligence (AI) is increasingly being utilised in the drug discovery process, with the latest…
Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
In Conversation
Debbie Hart – Founding President & CEO, BioNJ, USA
BioNJ’s president and CEO Debbie Hart reflects on the association’s mission of creating a robust and engaging life sciences ecosystem in New Jersey. Hart also outlines how BioNJ is hoping to continue to grow the region’s reputation as a hub that stands out for its level of expertise, favourable geographic location, and supportive governmental initiatives. Much of the research,…
Indian Generics Companies in the US Snapshot
The US generics market stood at USD 69 billion in 2018 and is expected to grow to USD 86 billion by 2022. Made…
Related Report
Indian Generics in the USA / Destined for More Success?
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
Opinion / Bringing Patient Experience to Regulatory Decision-Making: Communication Pathway Needed
Takeda’s Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug…
Internationalization / Chiesi Moves into Rare Diseases & the US Market
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
The Future of Biosimilars in the USA
Despite the savings and increased patient access biosimilars have brought to health care systems across Europe, the…
Investment / US Pharma Rewards its Shareholders
In 2019 big pharma companies prioritised shareholder payouts and dividends, with the eight biggest US pharma…
Generics / Opportunities to Fix Medicare Part D
The Association for Accessible Medicines’ Chip Davis outlines the ways in which the US Medicare programme…
Coronavirus / Worldwide Demand for Protective Masks Booms Amid Infection Fears
The 2019 Wuhan coronavirus outbreak has seen a surge in demand for protective masks as publics across the world…
Coronavirus / Indian Pharma Supply Chain Hit by Covid-19 Outbreak
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
How the USA’s CREATES Act Restores Competition to the Pharmaceutical…
Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) discusses…
USA: The Biosimilars Trade Opportunity
Chip Davis of the Association for Accessible Medicines argues for greater provision for access to affordable…